Rating History for Prelude Therapeutics (PRLD) by Barclays

More Stocks Rated by Barclays | Latest Ratings for PRLD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/28/2024 Peter Lawson Maintain Underweight
(N/A)		 1.00
(3.00)		  
 		   Details